EDGAR Filing Documents for 0001193125-22-061279

Form POSASR - Post-effective Amendment to an automatic shelf registration statement:

SEC Accession No. 0001193125-22-061279

Filing Date

2022-03-01

Accepted

2022-03-01 16:03:31

Documents

Effectiveness Date

2022-03-01

Document Format Files

Seq	Description	Document	Type	Size
1	POSASR	d320821dposasr.htm	POSASR	381681
2	EX-5.1	d320821dex51.htm	EX-5.1	16562
3	EX-5.2	d320821dex52.htm	EX-5.2	20730
4	EX-23.1	d320821dex231.htm	EX-23.1	1772
5	EX-FILING FEES	d320821dexfilingfees.htm	EX-FILING FEES	29092
6	GRAPHIC	g320821dsp50.jpg	GRAPHIC	10774
7	GRAPHIC	g320821g58b82.jpg	GRAPHIC	35290
	Complete submission text file	0001193125-22-061279.txt		510087

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1

Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018

Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)